RCUS Arcus Biosciences, Inc.
NYSE · SEC CIK 1724521 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $14.41M 24 sales by 7 insiders
- Filings on record
- 172 since 2021-08-05, latest 2026-08-24 17:52
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Jaen Juan C. | Pres | — | $9.22M |
| Jarrett Jennifer | COO | — | $2.17M |
| ROSEN TERRY J | CEO, Dir | — | $1.20M |
| Goeltz II Robert C. | CFO | — | $855.9K |
| Azoy Alexander | CAO | — | $432.5K |
| Tang Carolyn C. | GC | — | $318.5K |
| Markus Richard | Chief Medical Off | — | $210.1K |
| Ribas Antoni | Dir | — | — |
| Lambert Nicole | Dir | — | — |
| Lacey David L. | Dir | — | — |
Transactions 177
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-01-25 | 2024-01-23 | RCUS | Tang Carolyn C. | GC | A - Grant | $0.00 | +26.7K | 114.6K | +30% | $0 |
| I | 2024-01-04 | 2024-01-02 | RCUS | Jaen Juan C. | Pres, Dir | S - Sale | $20.09 | -6,975 | 1.22M | -0.6% | -$140.1K |
| 2024-01-04 | 2024-01-02 | RCUS | Goeltz II Robert C. | CFO | S - Sale | $20.00 | -2,004 | 51.8K | -4% | -$40.1K | |
| 2024-01-02 | 2023-12-29 | RCUS | ROSEN TERRY J | CEO, Dir | W - Inherited | $0.00 | +448 | 3.87M | +0.0% | $0 | |
| 2023-12-26 | 2023-12-22 | RCUS | Jarrett Jennifer | COO, Dir | S - Sale | $17.76 | -21.5K | 258.9K | -8% | -$382.2K | |
| 2023-12-22 | 2023-12-20 | RCUS | Azoy Alexander | CAO | D - Sale to Iss | $18.21 | -68 | 10.2K | -0.7% | -$1,238 | |
| M | 2023-12-20 | 2023-12-18+ | RCUS | Azoy Alexander | CAO | D - Sale to Iss | $17.92 | -1,308 | 10.3K | -11% | -$23.4K |
| M | 2023-12-20 | 2023-12-18+ | RCUS | ROSEN TERRY J | CEO, Dir | D - Sale to Iss | $17.92 | -27.7K | 3.87M | -0.7% | -$496.4K |
| M | 2023-12-20 | 2023-12-18+ | RCUS | Goeltz II Robert C. | CFO | D - Sale to Iss | $17.92 | -5,557 | 56.6K | -9% | -$99.6K |
| M | 2023-12-20 | 2023-12-18+ | RCUS | Jaen Juan C. | Pres, Dir | D - Sale to Iss | $17.92 | -12.4K | 307.7K | -4% | -$221.9K |
| M | 2023-12-20 | 2023-12-18+ | RCUS | Nuyten Dimitry SA | Chief Medical Off | D - Sale to Iss | $17.92 | -3,047 | 71.2K | -4% | -$54.6K |
| M | 2023-12-20 | 2023-12-18+ | RCUS | Tang Carolyn C. | GC | D - Sale to Iss | $17.92 | -8,067 | 87.9K | -8% | -$144.5K |
| M | 2023-12-20 | 2023-12-18+ | RCUS | Jarrett Jennifer | COO, Dir | D - Sale to Iss | $17.92 | -22.7K | 280.4K | -8% | -$407.5K |
| 2023-12-05 | 2023-12-01 | RCUS | Azoy Alexander | CAO | S - Sale | $14.95 | -282 | 11.6K | -2% | -$4,216 | |
| 2023-09-26 | 2023-09-22 | RCUS | Jarrett Jennifer | COO, Dir | S - Sale | $19.99 | -21.4K | 302.7K | -7% | -$427.2K | |
| 2023-09-20 | 2023-09-18 | RCUS | Jarrett Jennifer | COO, Dir | D - Sale to Iss | $20.40 | -12.5K | 324.1K | -4% | -$255.1K | |
| 2023-09-20 | 2023-09-18 | RCUS | Nuyten Dimitry SA | Chief Medical Off | D - Sale to Iss | $20.40 | -3,708 | 73.6K | -5% | -$75.6K | |
| 2023-07-31 | 2023-07-28 | RCUS | Jarrett Jennifer | COO, Dir | S - Sale | $20.25 | -45.0K | 336.6K | -12% | -$911.2K | |
| 2023-07-05 | 2023-07-03 | RCUS | Azoy Alexander | CAO | S - Sale | $20.41 | -1,018 | 11.6K | -8% | -$20.8K | |
| 2023-06-30 | 2023-06-28 | RCUS | GILEAD SCIENCES, INC. | 10% | P - Purchase | $19.26 | +1.01M | 14.82M | +7% | +$19.45M | |
| 2023-06-26 | 2023-06-22 | RCUS | Jarrett Jennifer | COO, Dir | S - Sale | $19.12 | -12.4K | 381.6K | -3% | -$237.8K | |
| 2023-06-16 | 2023-06-16 | RCUS | Jarrett Jennifer | COO, Dir | S - Sale | $19.35 | -12.6K | 394.0K | -3% | -$243.1K | |
| D | 2023-06-16 | 2023-06-15 | RCUS | Lambert Nicole | Dir | A - Grant | $0.00 | +6,800 | 15.6K | +77% | $0 |
| D | 2023-06-16 | 2023-06-15 | RCUS | Lacey David L. | Dir | A - Grant | $0.00 | +6,800 | 49.3K | +16% | $0 |
| 2023-06-16 | 2023-06-16 | RCUS | Tang Carolyn C. | GC | D - Sale to Iss | $19.35 | -2,892 | 95.9K | -3% | -$56.0K | |
| D | 2023-06-16 | 2023-06-15 | RCUS | KANEKO YASUNORI | Dir | A - Grant | $0.00 | +6,800 | 6,800 | New | $0 |
| D | 2023-06-16 | 2023-06-15 | RCUS | Machado Patrick | Dir | A - Grant | $0.00 | +6,800 | 16.9K | +67% | $0 |
| 2023-06-16 | 2023-06-16 | RCUS | Jaen Juan C. | Pres, Dir | D - Sale to Iss | $19.35 | -4,820 | 313.9K | -2% | -$93.3K | |
| 2023-06-16 | 2023-06-15 | RCUS | Jaen Juan C. | Pres, Dir | G - Gift | $0.00 | -6,000 | 318.7K | -2% | $0 | |
| D | 2023-06-16 | 2023-06-15 | RCUS | Ribas Antoni | Dir | A - Grant | $0.00 | +6,800 | 21.9K | +45% | $0 |
| D | 2023-06-16 | 2023-06-15 | RCUS | PERLMAN ANDREW J | Dir | A - Grant | $0.00 | +6,800 | 20.9K | +48% | $0 |
| 2023-06-16 | 2023-06-16 | RCUS | ROSEN TERRY J | CEO, Dir | D - Sale to Iss | $19.35 | -8,762 | 3.89M | -0.2% | -$169.5K | |
| D | 2023-06-16 | 2023-06-15 | RCUS | FALBERG KATHRYN E | Dir | G - Gift | $0.00 | -50.5K | 40.1K | -56% | $0 |
| D | 2023-06-16 | 2023-06-15 | RCUS | FALBERG KATHRYN E | Dir | A - Grant | $0.00 | +6,800 | 46.9K | +17% | $0 |
| 2023-06-09 | 2023-06-07 | RCUS | Goeltz II Robert C. | CFO | S - Sale | $20.04 | -4,049 | 59.4K | -6% | -$81.1K | |
| 2023-03-20 | 2023-03-16 | RCUS | Jarrett Jennifer | COO, Dir | S - Sale | $16.81 | -8,729 | 406.2K | -2% | -$146.7K | |
| M | 2023-01-30 | 2023-01-26+ | RCUS | Jarrett Jennifer | COO, Dir | S - Sale | $23.53 | -1,900 | 416.5K | -0.5% | -$44.7K |
| D | 2023-01-25 | 2023-01-23 | RCUS | Goeltz II Robert C. | CFO | A - Grant | $0.00 | +34.0K | 63.4K | +115% | $0 |
| D | 2023-01-25 | 2023-01-23 | RCUS | Jarrett Jennifer | COO, Dir | A - Grant | $0.00 | +45.8K | 416.8K | +12% | $0 |
| D | 2023-01-25 | 2023-01-23 | RCUS | Tang Carolyn C. | GC | A - Grant | $0.00 | +34.0K | 97.5K | +54% | $0 |
| D | 2023-01-25 | 2023-01-23 | RCUS | Nuyten Dimitry SA | Chief Medical Off | A - Grant | $0.00 | +34.0K | 76.5K | +80% | $0 |
| D | 2023-01-25 | 2023-01-23 | RCUS | Jaen Juan C. | Pres, Dir | A - Grant | $0.00 | +45.8K | 324.7K | +16% | $0 |
| D | 2023-01-25 | 2023-01-23 | RCUS | ROSEN TERRY J | CEO, Dir | A - Grant | $0.00 | +105.7K | 469.1K | +29% | $0 |
| M | 2022-12-16 | 2022-12-16 | RCUS | ROSEN TERRY J | CEO, Dir | S - Sale | $30.75 | -13.0K | 242.2K | -5% | -$401.1K |
| M | 2022-12-16 | 2022-12-16 | RCUS | Jaen Juan C. | Pres, Dir | S - Sale | $30.75 | -4,436 | 218.3K | -2% | -$136.4K |
| M | 2022-12-16 | 2022-12-16 | RCUS | Jarrett Jennifer | COO, Dir | S - Sale | $30.75 | -16.5K | 150.2K | -10% | -$506.8K |
| M | 2022-12-16 | 2022-12-16 | RCUS | Tang Carolyn C. | GC | S - Sale | $30.75 | -2,523 | 28.6K | -8% | -$77.6K |
| M | 2022-12-16 | 2022-12-16 | RCUS | Goeltz II Robert C. | CFO | S - Sale | $30.75 | -2,453 | 12.0K | -17% | -$75.4K |
| 2022-09-20 | 2022-09-16 | RCUS | Jarrett Jennifer | COO, Dir | S - Sale | $26.28 | -12.7K | 130.9K | -9% | -$333.2K | |
| D | 2022-08-24 | 2022-08-23 | RCUS | Nuyten Dimitry SA | Chief Medical Off | A - Grant | $0.00 | +42.5K | 42.5K | New | $0 |
| M | 2022-06-21 | 2022-06-16+ | RCUS | Jarrett Jennifer | COO, Dir | S - Sale | $21.45 | -12.7K | 125.2K | -9% | -$272.3K |
| M | 2022-06-21 | 2022-06-16+ | RCUS | Tang Carolyn C. | GC | S - Sale | $21.45 | -2,922 | 25.0K | -10% | -$62.7K |
| M | 2022-06-21 | 2022-06-16+ | RCUS | ROSEN TERRY J | CEO, Dir | S - Sale | $21.45 | -8,854 | 227.7K | -4% | -$189.9K |
| M | 2022-06-21 | 2022-06-16+ | RCUS | Jaen Juan C. | Pres, Dir | S - Sale | $21.45 | -4,870 | 210.0K | -2% | -$104.5K |
| D | 2022-06-16 | 2022-06-14 | RCUS | FALBERG KATHRYN E | Dir | A - Grant | $0.00 | +4,100 | 90.6K | +5% | $0 |
| D | 2022-06-16 | 2022-06-14 | RCUS | Ribas Antoni | Dir | A - Grant | $0.00 | +4,100 | 15.2K | +37% | $0 |
| D | 2022-06-16 | 2022-06-14 | RCUS | Lambert Nicole | Dir | A - Grant | $0.00 | +4,100 | 4,100 | New | $0 |
| D | 2022-06-16 | 2022-06-14 | RCUS | Lacey David L. | Dir | A - Grant | $0.00 | +4,100 | 42.5K | +11% | $0 |
| D | 2022-06-16 | 2022-06-14 | RCUS | Machado Patrick | Dir | A - Grant | $0.00 | +4,100 | 10.1K | +68% | $0 |
| D | 2022-06-16 | 2022-06-14 | RCUS | KANEKO YASUNORI | Dir | A - Grant | $0.00 | +4,100 | 4,100 | New | $0 |
| D | 2022-06-16 | 2022-06-14 | RCUS | PERLMAN ANDREW J | Dir | A - Grant | $0.00 | +4,100 | 11.1K | +58% | $0 |
| 2022-03-18 | 2022-03-16 | RCUS | Jarrett Jennifer | COO, Dir | S - Sale | $31.62 | -9,617 | 106.0K | -8% | -$304.1K | |
| D | 2022-03-10 | 2022-03-08 | RCUS | Goeltz II Robert C. | CFO | A - Grant | $0.00 | +15.5K | 22.5K | +221% | $0 |
| DI | 2022-03-10 | 2022-03-07 | RCUS | ROSEN TERRY J | CEO, Dir | G - Gift | $0.00 | -321.1K | 0 | -100% | $0 |
| D | 2022-03-10 | 2022-03-08 | RCUS | ROSEN TERRY J | CEO, Dir | A - Grant | $0.00 | +65.0K | 276.6K | +31% | $0 |
| D | 2022-03-10 | 2022-03-08 | RCUS | Tang Carolyn C. | GC | A - Grant | $0.00 | +16.2K | 33.8K | +93% | $0 |
| D | 2022-03-10 | 2022-03-08 | RCUS | Jaen Juan C. | Pres, Dir | A - Grant | $0.00 | +31.2K | 232.4K | +16% | $0 |
| D | 2022-03-10 | 2022-03-08 | RCUS | Jarrett Jennifer | COO, Dir | A - Grant | $0.00 | +31.2K | 121.8K | +34% | $0 |
| I | 2022-03-02 | 2022-02-28 | RCUS | Jaen Juan C. | Pres, Dir | G - Gift | $0.00 | -350.0K | 1.22M | -22% | $0 |
| M | 2021-12-22 | 2021-12-20 | RCUS | Jarrett Jennifer | COO, Dir | S - Sale | $41.48 | -34.8K | 114.3K | -23% | -$1.44M |
| M | 2021-12-20 | 2021-12-16+ | RCUS | Jaen Juan C. | Pres, Dir | S - Sale | $40.12 | -1,973 | 201.2K | -1.0% | -$79.2K |
| M | 2021-12-20 | 2021-12-16+ | RCUS | ROSEN TERRY J | CEO, Dir | S - Sale | $40.12 | -5,242 | 214.5K | -2% | -$210.3K |
| M | 2021-12-20 | 2021-12-16+ | RCUS | Goeltz II Robert C. | CFO | S - Sale | $40.12 | -1,106 | 7,019 | -14% | -$44.4K |
| M | 2021-12-20 | 2021-12-16+ | RCUS | Jarrett Jennifer | COO, Dir | S - Sale | $40.12 | -12.7K | 131.0K | -9% | -$508.7K |
| M | 2021-12-20 | 2021-12-16+ | RCUS | Tang Carolyn C. | GC | S - Sale | $40.12 | -1,109 | 18.0K | -6% | -$44.5K |
| M | 2021-09-22 | 2021-09-20+ | RCUS | Jarrett Jennifer | COO, Dir | S - Sale | $35.35 | -47.5K | 112.8K | -30% | -$1.68M |
| D | 2021-08-05 | 2021-08-03 | RCUS | Lambert Nicole | Dir | A - Grant | $0.00 | +4,700 | 4,700 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations